Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Katie Barletta
Observed name:
K. Barletta
Institutions:
Ferring Pharmaceuticals (United States),
Ferring Pharmaceuticals (Denmark)
Observed institutions:
Ferring Pharmaceuticals (United States),
Ferring Pharmaceuticals (Denmark)
ORCID:
0000-0001-8082-1885
Observed ORCID:
0000-0001-8082-1885
OpenAlex ID:
A5139412797
The Effect of Carbetocin on Cardiac Repolarization: A Randomized, Placebo‐ and Positive‐Controlled QT / QTc Study in Healthy Adults
2026
·
Daniël M. Jonker
, Katie Barletta
, et al.
·
Clinical and Translational Science
PDF
L26/P-759 Machine learning prediction of usable blastocyst yield in hp-hMG-only ICSI cycles: A multicenter retrospective analysis
2026
·
A. Luz
, N. Itzhak
, et al.
·
Human Reproduction
L26/P-223 Key predictors of usable blastocyst yield in highly purified human menopausal gonadotropin (hp-hMG) only cycles: a multicenter machine learning analysis
2026
·
N. Itzhak
, A. Luz
, et al.
·
Human Reproduction
Hsd94 U.s. Real-world Prescribing Patterns of Mixed Gonadotropin Ovarian Stimulation Protocols: a Claims-based Analysis
2026
·
Kinsuk Chauhan
, Udit R
, et al.
·
Value in Health
Hsd44 Real-world Insights on Controlled Ovarian Stimulation for Ivf/icsi: Data From a Large Fertility Emr Database in the Us (2010 - 2024)
2026
·
Monica Yu
, Katie Barletta
, et al.
·
Value in Health
Show more works
View as search
Works count:
5
Citation count:
H-index:
I10-index:
Year
Topic
Type